Tenon Medical, Inc. (TNON) vs Vivos Therapeutics, Inc. (VVOS)

A side-by-side comparison of Tenon Medical, Inc. and Vivos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — TNON vs VVOS

growth of $100 · dividends reinvested · last 4y
TNON -100.0% (-91.2%/yr)VVOS -99.6% (-75.7%/yr)VVOS compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $1002023202420252026$0$0
TNON VVOS

TNON vs VVOS: by the numbers

  • •VVOS is the larger company ($2M vs $2M market cap).
  • •Both run net losses; VVOS's is the smaller (-122.42% vs -256.33% net margin).
  • •TNON grew revenue faster over the past five years (150.91% vs 7.52% CAGR).

Metrics side by side

Valuation

MetricTNONVVOS
P/S ratio0.350.10

Profitability

MetricTNONVVOS
Gross margin66.25%59.72%
Operating margin-324.34%-107.92%
Net margin-256.33%-122.42%
ROIC-217.28%-182.30%

Growth (annualized)

MetricTNONVVOS
Revenue CAGR (5Y)150.91%7.52%
Total return CAGR (5Y)N/A-72.60%

Frequently asked

Which has grown faster, TNON or VVOS?
Over the past five years, TNON grew revenue faster — TNON at a 150.91% CAGR versus VVOS at 7.52%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.